Influence of genetic susceptibility on the urinary excretion of 8-hydroxydeoxyguanosine of firefighters

Occupational and Environmental Medicine

Volumn 57, Issue 6, 2000, Pages 370-375

  Hong, Yun Chul ^a   Park, Hye Sook ^a   Ha, Eun Hee ^b  

^a Inha University School of Medicine   (South Korea)

^b Ewha Womans University School of Medicine   (South Korea)

Author keywords

8 hydroxydeoxyguanosine; Firefighters; Susceptibility

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; CARCINOGEN; CREATININE; DIMETHYLNITROSAMINE DEMETHYLASE; ETHOXYRESORUFIN DEETHYLASE; GLUTATHIONE TRANSFERASE;

ADULT; AGE; ARTICLE; BODY MASS; CHEMICAL CARCINOGENESIS; CIGARETTE SMOKING; DNA DAMAGE; DNA REPAIR; ENZYME LINKED IMMUNOSORBENT ASSAY; FIRE; FIRE FIGHTER; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MULTIPLE REGRESSION; OCCUPATIONAL EXPOSURE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; CELL TRANSFORMATION, NEOPLASTIC; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP2E1; DEOXYGUANOSINE; DNA DAMAGE; FIRES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; REGRESSION ANALYSIS; SMOKING;

EID: 0034024265     PISSN: 13510711     EISSN: None     Source Type: Journal    
DOI: 10.1136/oem.57.6.370     Document Type: Article

References (35)

1. Brandt-Rauf PW, Fallon LF Jr, Tarantini T, et al. Health hazards of fire fighters: exposure assessment. Br J Ind Med 1998:45:606-12.
2. Beaumont JJ, Chu GST, Jones JR, et al. An epidemiologic study of cancer and other causes of mortality in San Francisco firefighters. Am J Ind Med 1991:19:357-72.
3. Golden AL, Markowitz SB, Landrigan PJ. The risk of cancer in firefighters. Occup Med 1995:10:803-20.
4. Feuer E, Rosenman K. Mortality in police and firefighters in New Jersey. Am J Ind Med 1986:9:517-27.
5. Sama SR, Martin TR, Davis L, et al. Cancer incidence among Massachusetts firefighters: 1982-6. Am J Ind Med 1990:18:47-54.
6. Aronson KJ, Tomlinson GA, Smith L. Mortality among fire fighters in metropolitan Toronto. Am J Ind Med 1994:26: 89-101.
7. Heyer N, Weiss NS, Demers P, et al. Cohort mortality study of Seattle fire fighters: 1945-1983. Am J Ind Med 1990:17: 493-504.
8. Burnett CA, Halperin WE, Lalich NR, et al. Mortality among fire fighters: a 27 state survey. Am J Ind Med 1994: 26:831-3.
9. Tornling G, Gustavsson P, Hogstedt C. Mortality and cancer incidence in Stockholm fire fighters. Am J Ind Med 1994:25:219-28.
10. Inoue T, Mu Z, Sumikawa K, et al. Effect of physical exercise on the content of 8-hydroxydeoxyguanosine in nuclear DNA prepared from human lymphocytes. Jpn J Cancer Res 1993:84:720-5.
11. Loft S, Vistisen K, Ewertz M, et al. Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass index. Carcinogenesis 1992:13:2241-7.
12. Golden AL, Markowitz SB, Landrigan PJ. The risk of cancer in firefighters. Occup Med 1995:10:803-20.
13. Lees PSJ. Combustion products and other firefighter exposures Occup Med 1995:10:691-706.
14. Kuori RE, McKinney CE, Slomiany DJ, et al. Positive correlation between high aryl hydrocarbon hydroxylase activity and primary lung cancer as analysed in cryopreserved lymphocytes. Cancer Res 1982:42:5030-7.
15. Kawajiri K, Nakachi K, Imai K, et al. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P4501A1 gene. FEBS Lett 1990:263:131-3.
16. Hayashi S, Watanabe J, Nakachi K, et al. Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P4501A1 gene. J Biochem 1991:110:407-11.
17. Nakachi K, Imai K, Hayashi S, et al. Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res 1991:51:5177-80.
18. Kihara M, Kihara M, Noda K. Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population. Carcinogenesis 1995:16: 2331-6.
19. Guengerich FP, Kim DH, Iwasaki M. Role of human cytochrome P-450IIEI in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol 1991:4:168-79.
20. Villard PH, Seree E, Lacarelle B, et al. Effect of cigarette smoke on hepatic and pulmonary cytochrome P450 in mouse: evidence for CYP2E1 induction in lung. Biochem Biophys Res Commun 1994:202:1731-7.
21. Hayashi S, Watanabe J, Kawajiri K. Genetic polymorphisms in the 5′-flanking region change trascriptional regulation of the human cytochrome P450IIEI gene. J Biochem 1991: 110:559-65.
22. Yu M, Gladek-Yarborough A, Chiamprasert S, et al. Cytochrome P450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. Gastroenterology 1995:109:1266-73.
23. Hung HC, Chuang J, Chien YC, et al. Genetic polymorphisms of CYP2E1, GSTM1, and GSTT1; environmental factors and risk of oral cancer. Cancer Epidemiol Biomarkers Prev 1997:6:901-5.
24. Katoh T, Nagata N, Kuroda Y, et al. Glutathione S-transferase M1(GSTM1) and T1(GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis 1996:17:1855-9.
25. Nakajima T, Elovaara E, Anttila S, et al. Expression and polymorphism of glutathione S-transferase in human lungs: risk factors in smoking-related lung cancer. Carcinogenesis 1995:16:707-11.
26. Kihara M, Kihara M, Noda K. Lung cancer risk of GSTM1 null genotype is dependent on the extent of tobacco smoke exposure. Carcinogenesis 1994:15:415-18.
27. Hirvonen A, Pelin K, Tammilehto L, et al. Inherited GSTM1 and NAT2 defects as concurrent risk modifiers in asbestos-related human malignant mesothelioma. Cancer Res 1995:55:2981-3.
28. Elexpuru-Camiruaga J, Buxton N, Kandula V, et al. Susceptibility to astrocytoma and meningioma: influence of allelism at glutathione S-transferase (GSTT1 and GSTM1) and cytochrome P-450 (CYP2D6) loci. Cancer Res 1995:55:4237-9.
29. Deakin M, Elder J, Hendrickse C, et al. Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric, and colorectal cancers. Carcinogenesis 1996:17:881-4.
30. Bergtold DS, Berg CD, Simic MG. Urinary biomarkers in radiation therapy of cancer. Adv Exp Med Biol 1990:264: 311-16.
31. Kasai H, Nishimura S, Kurokawa Y, et al. Oral administration of the renal carcinogen, potassium bromate, specifically produces 8-hydroxydeoxyguanosine in rat target organ DNA. Carcinogenesis 1987:8:1959-61.
32. Kasai H, Crain PF, Kuchino Y, et al. Formation of 8-hydroxyguanine moiety in cellular DNA by agents producing oxygen radicals and evidence for its repair. Carcinogenesis 1986:7:1849-51.
33. Sigenaga M, Gimeno CJ, Ames BN. Urinary 8-hydroxy-2-deoxyguanosine as a biological marker of in vivo oxidative DNA damage. Proc Natl Acad Sci USA 1989:86:9697-701.
34. Leanderson P, Tagesson C. Cigarette smoke-induced DNA damage: role of hydroquinone and catechol in the formation of the oxidative DNA-adduct, 8-hydroxydeoxyguanosine. Chem Biol Interact 1990:75:71-81.
35. Leanderson P, Tagesson C. Cigarette smoke-induced DNA damage in cultured human lung cells: role of hydroxyl radicals and endonuclease activation. Chem Biol Interact 1992:810:197-208.